mirvetuximab soravtansine Injectable Product

RxNorm concept 2621551, clinical dose form group (scdg).

RxCUI: 2621551
Term type: Clinical dose form group (SCDG)
Status: Active

Request

curl https://api.healthcare.dev/v1/drugs/rxnorm/2621551 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Concept

Ingredients and related concepts

Ingredients

mirvetuximab soravtansine 2621548

Related concepts

mirvetuximab soravtansine (IN, has ingredient)
Elahere Injectable Product (SBDG, has tradename)

Linked data

NDCs

RxNorm links no NDCs to this concept.

Use it

Look up 2621551 from code or an agent

curl

curl https://api.healthcare.dev/v1/drugs/rxnorm/2621551 \
  -H "Authorization: Bearer $HDEV_API_KEY"

MCP prompt

Using the healthcare.dev MCP server, look up RxNorm concept 2621551. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.

Get a free key RxNorm docs Connect the MCP server

Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.